J Frontier Co.,Ltd. cancelled the acquisition of my's Co., Ltd. from Muna Miyashita.
January 23, 2022
Share
J Frontier Co.,Ltd. (TSE:2934) signed a basic agreement to acquire my's Co., Ltd. from Muna Miyashita on November 30, 2021. J Frontier Co.,Ltd. will acquire 100 shares of my's Co., Ltd. As on June 30, 2021, my's Co., Ltd. reported Net assets ¥5 million, Total assets ¥193 million, Sales ¥210 million, Ordinary profit ¥6 million and Net profit ¥4 million. Share transfer agreement will be signed on December 24, 2021 and transaction is expected to complete on December 28, 2021.
J Frontier Co.,Ltd. (TSE:2934) cancelled the acquisition of my's Co., Ltd. from Muna Miyashita on January 24, 2022.
J Frontier Co Ltd is a Japan-based company mainly engaged in the electronic commerce sale business for healthcare-related products and pharmaceuticals, the provision of online medication guidance, drug delivery platform SOKUYAKU, as well as the Internet advertising agency business for healthcare-related services. The Company operates through three business segments. The Healthcare Sales segment is engaged in the planning and development of health foods and cosmetics represented by the 328 selection series of fermented hydrogen and mail-order sales. The Medical Care Sales segment is engaged in the operation of dispensing pharmacies, mail-order business of ethical drugs, as well as planning, development and mail-order sales of drugs such as Why Pure series and Chinese herbs. The Health Care Marketing segment is mainly engaged in advertising agency business related to health care products, sales promotion support for health care products, as well as wholesale of in-house products.
J FRONTIER CO.,LTD. 
